Utilizing risk scores in determining the optimal revascularization strategy for complex coronary artery disease

Current Cardiology Reports

Volumn 13, Issue 5, 2011, Pages 415-423

  Farooq, Vasim ^a   Brugaletta, Salvatore ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ACEF; Clinical SYNTAX score; Complex coronary artery disease; EuroSCORE; Functional SYNTAX score; Global risk; Mayo clinic risk score; NERS; Revascularization strategy; Risk scores; SYNTAX score

Indexed keywords

AGE CREATININE AND EJECTION FRACTION SCORE; AMERICAN COLLEGE OF CARDIOLOGY SCORE; AMERICAN HEART ASSOCIATION LESION CLASSIFICATION SYSTEM SCORE; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; EUROPEAN SYSTEM FOR CARDIAC OPERATIVE RISK EVALUATION; GLOBAL RISK SCORE; HUMAN; INTERMETHOD COMPARISON; NEW RISK CLASSIFICATION SCORE; PARSONNET SCORE; PATIENT ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SYNERGY BETWEEN PERCUTANEOUS CORONARY INTERVENTION WITH TAXUS AND CARDIAC SURGERY SCORE;

CATHETER ABLATION; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DECISION MAKING; FEMALE; HUMANS; MALE; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS;

EID: 81255157952     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-011-0202-5     Document Type: Article

References (59)

1. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-72.
2. Kappetein AP, Feldman TE, Mack MJ, Morice M, Holmes DR, Ståhle E, et al. Comparison of Coronary Bypass Surgery with Drug-eluting Stenting for the Treatment of Left Main and/or Three-vessel Disease: Three-year follow-up of the SYNTAX trial. In Press 2011.
3. Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP Holmes Jr DR, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Hear J. 2006;151 (6):1194-204. (Pubitemid 44172867)
4. Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 38 Suppl:S1-S52.
5. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Euro J Cardiothorac Surg: official journal of the European Association for Cardio-thoracic Surgery. 1999;16(1):9-13. (Pubitemid 29336425)
6. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Hear J. 2003;24(9):881-2.
7. Serruys PW, Onuma Y Garg S, Sarno G, van den Brand M, Kappetein AP, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 5(1):50-56.
8. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation. 1981;63(2):285-99.
9. Sianos G, Morel MA APK, Morice MC, Colombo A, Dawkins K, van den Brand M, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219-27
10. Coronary Stenosis Imaging, Structure and Physiology. Javier Escaned. Patrick W Serruys. PCR Publishing; 2011.
11. Khattab AA, Hamm CW, Senges J, Toelg R, Geist V, Bonzel T, et al. Prognostic value of the modified American College of Cardiology/American Heart Association lesion morphology classification for clinical outcome after sirolimus-eluting stent placement (results of the prospective multicenter German Cypher Registry). Am J Cardiol. 2008;101(4):477-82. (Pubitemid 351210629)
12. Valgimigli M, Dawkins K, Macaya C, de Bruyne B, Teiger E, Fajadet J, et al. Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multi-vessel revascularization with sirolimus-eluting stents: a subanal-ysis of the ARTS II trial. J Am Coll Cardiol. 2007;49(4):431-41. (Pubitemid 46156980)
13. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv. 2009;2(4):302-8
14. SYNTAX score calculator: http://www.syntaxscore.com.SYNTAX working-group. Launched 19th May 2009.
15. Garg S, Stone GW, Kappetein AP, Sabik JF, Simonton C, Serruys PW. Clinical and angiographic risk assessment in patients with left main stem lesions. JACC Cardiovasc Interv. 2010;3(9):891-901.
16. Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol. 2010;56(4):272-7.
17. Mohr FW, Rastan AJ, Serruys PW, Kappetein AP, Holmes DR, Pomar JL, et al. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg. 2011;141(1):130-40.
18. Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55(25):2816-21.
19. Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010;56(3):177-84.
20. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360 (3):213-24.
21. Fearon WF. Functional Syntax score. Presented at: Left Main Coronary Interventions Course; February 14, 2011; New York, NY.
22. Cutlip DE, Mehran R, Vranckx P. FAME and coronary stent investigations: is there a kink in the wire? J Am Coll Cardiol. 2011;57(1):115-6. author reply 116.
23. Garg S, Girasis C, Sarno G, Goedhart D, Morel MA, Garcia-Garcia HM, et al. The SYNTAX score revisited: a reassessment of the SYNTAX score reproducibility. Catheter Cardio Interv. 75 (6):946-952
24. Singh M, Rihal CS, Lennon RJ, Spertus J, Rumsfeld JS, Holmes Jr DR. Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores. Mayo Clin Proc. 2007;82(6):701-8. (Pubitemid 46878093)
25. Singh M, Gersh BJ, Li S, Rumsfeld JS, Spertus JA, O'Brien SM, et al. Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery. Circulation. 2008;117(3):356-62.
26. Gogbashian A, Sedrakyan A, Treasure T. EuroSCORE: a systematic review of international performance. Eur J Cardio-thorac Surg. 25(5):695-700
27. Kim YH, Ahn JM, Park DW, Lee BK, Lee CW, Hong MK, et al. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am J Cardiol. 2006;98(12):1567-70. (Pubitemid 44827961)
28. Romagnoli E, Burzotta F, Trani C, Siviglia M, Biondi-Zoccai GG, Niccoli G, et al. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart. 2009;95(1):43-8.
29. Kim YH, Park D-W, Kim W-J, Lee J-Y Yun S-C, Kang S-J, et al. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. J Am Coll Cardiol Intv. 2010;3 (6):612-23.
30. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121(24):2645-53.
31. Rodes-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, et al. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation. 2008;118(23):2374-81.
32. Onuma Y Girasis C, Piazza N, Garcia-Garcia HM, Kukreja N, Garg S, et al. Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv. 2010;3(6):584-94.
33. Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119(24):3053-61.
34. Ranucci M, Castelvecchio S. The ACEF score one year after: a skeleton waiting for muscles, skin, and internal organs. Euro-Intervention. 6(5):549-553.
35. Wykrzykowska JJ, Garg S, Onuma Y de Vries T, Goedhart D, Morel MA, et al. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the All-Comers' LEADERS trial. Circ Cardiovasc Interv. 2011;4(1):47-56.
36. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989;79(6 Pt 2):I3-12.
37. Valgimigli M, van Mieghem CAG, Ong ATL, Aoki J, Granillo GAR, McFadden EP, et al. Short-and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the rapamycin-eluting and taxus stent evaluated at rotterdam cardiology hospital registries (RESEARCH and T-SEARCH). Circulation. 2005;111(11):1383-9. (Pubitemid 40396804)
38. Chakravarty T, Buch MH, Naik H, White AJ, Doctor N, Schapira J, et al. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol. 2011;107(3):360-6.
39. Walter J, Mortasawi A, Arnrich B, Albert A, Frerichs I, Rosendahl U, et al. Creatinine clearance versus serum creatinine as a risk factor in cardiac surgery. BMC Surg. 2003;3:4.
40. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
41. Garg S, Sarno G, Garcia-Garcia HM, Girasis C, Wykrzykowska J, Dawkins KD, et al. A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score. Circ Cardiovasc Interv. 2010;3(4):317-26.
42. Serruys PW, Ong AT, Morice MC, De Bruyne B, Colombo A, Macaya C, et al. Arterial Revascularisation Therapies Study Part II-Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention. 1(2):147-156.
43. Capodanno D, Caggegi A, Miano M, Cincotta G, Dipasqua F, Giacchi G, et al. Global risk classification and clinical SYNTAX (Synergy between percutaneous coronary intervention with TAX-US and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization. J Am Coll Cardiol Intv. 2011;4(3):287-97.
44. Chen S-L, Chen JP, Mintz G, Xu B, Kan J, Ye F, et al. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting. J Am Coll Cardiol Intv. 2010;3 (6):632-41.
45. Serruys PW Integrating lessons from recent clinical trials into practice: beyond the SYNTAX score. Presented at: Transcatheter Therapeutics Asia Pacific; April 29, 2010; Seoul, South Korea; 2010.
46. Capodanno D, Miano M, Cincotta G, Caggegi A, Ruperto C, Bucalo R, et al. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Hear J. 2010;159(1):103-9.
47. Capodanno D, Capranzano P, Di Salvo ME, Caggegi A, Tomasello D, Cincotta G, et al. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv. 2009;2 (8):731-8.
48. Federspiel J, Stearns SC, van Domburg R, Sheridan BC, Lund J, Serruys PW Risk-benefit trade-offs in revascularisation choices. EuroInternvention 2011, Epub ahead of print.
49. van Domburg RT, Daemen J, Morice MC, de Bruyne B, Colombo A, Macaya C, et al. Short-and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroIntervention. 5(8):962-967.
50. Cohen DJ, Van Hout B, Serruys PW, Mohr FW Macaya C, den Heijer P, et al. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med. 364(11):1016-1026.
51. Graham MM, Faris PD, Ghali WA, Galbraith PD, Norris CM, Badry JT, et al. Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort. Am Hear J. 2001;142(2):254-61. (Pubitemid 32706283)
52. Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55(18):1923-32.
53. O'Connor GT, Plume SK, Olmstead EM, Coffin LH, Morton JR, Maloney CT, et al. Multivariate prediction of in-hospital mortality associated with coronary artery bypass graft surgery. Northern New England Cardiovascular Disease Study Group. Circulation. 1992;85(6):2110-8.
54. Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP et al. Risk stratification of in-hospital mortality for coronary artery bypass graft surgery. J Am Coll Cardiol. 2006;47(3):661-8. (Pubitemid 43170860)
55. Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75 (6):1856-64. discussion 1864-1855.
56. Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2-22.
57. Ad N, Barnett SD, Speir AM. The performance of the EuroSCORE and the Society of Thoracic Surgeons mortality risk score: the gender factor. Interact Cardiovasc Thorac Surg. 2007;6 (2):192-5. (Pubitemid 46596944)
58. Madan P, Elayda MA, Lee VV, Wilson JM. Predicting major adverse cardiac events after percutaneous coronary intervention: t. Am Hear J. 2008;155(6):1068-74.
59. Wu C, Hannan EL, Walford G, Ambrose JA, Holmes Jr DR, King 3rd SB, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol. 2006;47 (3):654-60. (Pubitemid 43170859)